<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">As to potentially effective therapies, there are several trials to assess their safety and efficacy as potential treatments for COVID-19, such as antivirals, systemic interferons, non-steroidal anti-inflammatories, dexamethasone, chloroquine/hydroxychloroquine, and monoclonal antibodies against interleukin-6 (IL-6) and IL-4
 <xref rid="bib0190" ref-type="bibr">18</xref>, 
 <xref rid="bib0195" ref-type="bibr">19</xref>, 
 <xref rid="bib0200" ref-type="bibr">20</xref> (
 <ext-link ext-link-type="uri" xlink:href="https://www.ecdc.europa.eu/en/covid-19/latest-evidence/vaccines-and-treatment" id="intr0010" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ecdc.europa.eu/en/covid-19/latest-evidence/vaccines-and-treatment</ext-link>).
</p>
